Heron Therapeutics
HRTX
$2.45
Share price
-3.92%
Change (1 day)
2.51%
Change (1 year)
Categories
EPS for Heron Therapeutics (HRTX)
EPS in 2023 (TTM): -$1.17
According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.17. In 2022 the company made an earnings per share (EPS) of -$1.73 an increase over its 2021 EPS that were of -$2.25.
EPS history for Heron Therapeutics from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$1.17 | -32.37% |
| 2022 | -$1.73 | -23.11% |
| 2021 | -$2.25 | -10% |
| 2020 | -$2.50 | -0% |
| 2019 | -$2.50 | 1.21% |
| 2018 | -$2.47 | -32.7% |
| 2017 | -$3.67 | -19.34% |
| 2016 | -$4.55 | 54.76% |
| 2015 | -$2.94 | 1.73% |
| 2014 | -$2.89 | -16.23% |
| 2013 | -$3.45 | 91.67% |
| 2012 | -$1.80 | -31.45% |
| 2011 | -$2.63 | -27.06% |
| 2010 | -$3.60 | -43.75% |
| 2009 | -$6.40 | -57.33% |
| 2008 | -$15.00 | -82.92% |
| 2007 | -$87.80 | 20.61% |
| 2006 | -$72.80 | 175.76% |
| 2005 | -$26.40 | -21.43% |
| 2004 | -$33.60 | 100% |
| 2003 | -$16.80 | -38.24% |
| 2002 | -$27.20 | 161.54% |
| 2001 | -$10.40 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 SurModics SRDX | -$1.65 | 41.03% | 🇺🇸 USA |
 Pacira Biosciences
PCRX | $0.14 | -111.97% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $1.57 | -234.19% | 🇺🇸 USA |
 Alkermes ALKS | $1.30 | -211.11% | 🇮🇪 Ireland |
 Nektar Therapeutics
NKTR | -$1.63 | 39.32% | 🇺🇸 USA |